✦ LIBER ✦

9046 A phase II retrospective trial of Platinum/Gemcitabine (P/G)-based in first line treatment of advanced NSCLC with genetic polymorphisms analysis

✍ Scribed by Meacci, M.; Ludovini, V.; Pistola, L.; Floriani, I.; Foglietta, J.; Chiari, R.; Tofanetti, F.R.; Flacco, A.; Ferraldeschi, M.; Crinò, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-457 Docetaxel/gemcitabine vs. cisplati

✍ Binder, D.; Schweisfurth, H.; Grah, C.; Schäper, C.; Temmesfeld-Wollbrück, B.; S 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB

9081 A phase II retrospective trial of C

✍ Ludovini, V.; Pistola, L.; Floriani, I.; Meacci, M.; Chiari, R.; Stocchi, L.; To 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A phase II trial of weekly chemotherapy

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

P-476 Phase II study of gemcitabine plus

✍ Domènech, M.; Losa, F.; Blanco, R.; Nogué, M.; Montesinos, J.; Mesía, C.; Gallar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 295 KB

A phase II study of docetaxel (D) and ge

✍ Agelaki, S.; Papadakis, E.; Tsiafaki, X.; Rapti, A.; Toubis, M.; Bania, E.; Kalb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Docetaxel/gemcitabine or cisplatin/gemci

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB